InvestorsHub Logo
Followers 14
Posts 2972
Boards Moderated 0
Alias Born 07/19/2006

Re: der246 post# 19199

Saturday, 06/14/2014 12:37:07 AM

Saturday, June 14, 2014 12:37:07 AM

Post# of 30990

Without a doubt it MUST significantly lower or suppress inflamation and in turn effectively treat the targeted disease more than the placebo to gain approval.



None of this is necessarily true

What happens if the disease is left untreated for 20 years?



Anatabine is not treating the disease in most cases, but potentially the symptoms. Unless the disease is inflammation...

Usually it's a teaming or partnership arrangement.



Wrong. For a fledgeling biotech, it is usually dilution at the shareholders expense

If we get FDA approval the PPS goes viral.


More than likely, pps will go viral well before FDA approval. It would be the procession of successful trials that would spike the share price.

If not we are bankrupt.



That is far from reality. For example, they could go bankrupt far sooner then, or much later then, a hypothetical FDA decison/rejection

IMO Dr. Mullen is a respected SCIENTIST so are the 60 SCIENTISTS at Roskamp. Are they all Conspiring to commit a fraud?



If they are human, they are fallible. So far, this is research, not fact. Research is mostly trial and error, that is expected. No one said anything about fraud. That is your own paranoid reaction, not mine.

Are all the prestigious Universities in Europe embracing Dr. Mullen in NILVAD



Is that the case? Feel free to furnish evidence to support this bold statement.

On 3/20 Dr. Mullen and Dr Chapman set forth a timeline. Phase 2 begins early 2015... 6 short months from now.



You obviously are not familiar with biotech timelines. Don't hold your breath. Time frames always slip in this biz...it is baked into the cake, or should be anyway.

They would not say that if they didn't have funding.



More naïveté. There is no escrow/earmark for this, I don't believe. But no worries, if they run low on capital, they usually can dilute time and time again to stay solvent. However, maybe you should worry...there is always a good chance we will lose 90% of our investment.

We will know in 12 to 18 months if world renowned Dr. Mullen and the 60 Roskamp scientists with PHd degrees are competant.



So...If anatabine fails, these scientists are incompetent? That is a pretty superficial way to look at it. Sometimes things, ideas, or theories don't work out, no matter how bright individuals are. Is that their fault, or the molecule's? You decide...

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.